News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
236,707 Results
Type
Article (5397)
Company Profile (24)
Press Release (231286)
Multimedia
Podcasts (3)
Webinars (4)
Section
Business (83257)
Career Advice (470)
Deals (15239)
Drug Delivery (9)
Drug Development (19467)
Employer Resources (30)
FDA (3979)
Job Trends (4050)
News (122135)
Policy (7760)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (307)
Accelerated approval (6)
Adcomms (5)
Allergies (16)
Alliances (15181)
ALS (38)
Alzheimer's disease (298)
Antibody-drug conjugate (ADC) (40)
Approvals (4097)
Artificial intelligence (94)
Autoimmune disease (28)
Automation (6)
Bankruptcy (98)
Best Places to Work (2998)
Biosimilars (33)
Biotechnology (23)
Bladder cancer (39)
Brain cancer (8)
Breast cancer (112)
Cancer (963)
Cardiovascular disease (69)
Career advice (402)
Career pathing (3)
CAR-T (68)
CDC (2)
Cell therapy (177)
Cervical cancer (7)
Clinical research (17042)
Collaboration (369)
Compensation (374)
Complete response letters (9)
COVID-19 (329)
CRISPR (14)
C-suite (342)
Cystic fibrosis (28)
Data (1394)
Denatured (1)
Depression (25)
Diabetes (80)
Diagnostics (2262)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (33)
Drug pricing (17)
Drug shortages (2)
Duchenne muscular dystrophy (37)
Earnings (43097)
Editorial (6)
Employer branding (6)
Employer resources (32)
Events (39718)
Executive appointments (433)
FDA (4767)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (351)
Gene editing (26)
Generative AI (6)
Gene therapy (112)
GLP-1 (154)
Government (455)
Guidances (199)
Healthcare (5250)
HIV (10)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (43)
Immuno-oncology (10)
Indications (17)
Infectious disease (356)
Inflammatory bowel disease (37)
Inflation Reduction Act (4)
Influenza (7)
Intellectual property (33)
Interviews (56)
IPO (7944)
IRA (4)
Job creations (1142)
Job search strategy (366)
JPM (4)
Kidney cancer (10)
Labor market (10)
Layoffs (109)
Leadership (5)
Legal (2356)
Liver cancer (21)
Longevity (2)
Lung cancer (113)
Lymphoma (76)
Machine learning (3)
Management (10)
Manufacturing (148)
MASH (50)
Medical device (4172)
Medtech (4185)
Mergers & acquisitions (7710)
Metabolic disorders (222)
Multiple sclerosis (18)
NASH (6)
Neurodegenerative disease (54)
Neuropsychiatric disorders (13)
Neuroscience (550)
NextGen: Class of 2026 (1708)
Non-profit (748)
Now hiring (5)
Obesity (88)
Opinion (37)
Ovarian cancer (26)
Pain (28)
Pancreatic cancer (38)
Parkinson's disease (50)
Partnered (6)
Patents (54)
Patient recruitment (102)
Peanut (6)
People (25454)
Pharmaceutical (7)
Pharmacy benefit managers (2)
Phase 1 (5106)
Phase 2 (7389)
Phase 3 (5942)
Pipeline (2022)
Policy (20)
Postmarket research (629)
Preclinical (1971)
Press Release (66)
Prostate cancer (57)
Psychedelics (3)
Radiopharmaceuticals (111)
Rare diseases (188)
Real estate (1928)
Recruiting (8)
Regulatory (5799)
Reports (18)
Research institute (317)
Resumes & cover letters (69)
Rett syndrome (19)
RNA editing (1)
RSV (2)
Schizophrenia (49)
Series A (53)
Series B (55)
Sickle cell disease (11)
Special edition (1)
Spinal muscular atrophy (34)
Sponsored (5)
Startups (1030)
Stomach cancer (1)
Supply chain (18)
Tariffs (8)
The Weekly (2)
Vaccines (85)
Venture capital (9)
Weight loss (33)
Women's health (8)
Date
Today (12)
Last 7 days (152)
Last 30 days (541)
Last 365 days (9174)
2026 (816)
2025 (9317)
2024 (11325)
2023 (13535)
2022 (19058)
2021 (20114)
2020 (18585)
2019 (13473)
2018 (10397)
2017 (10245)
2016 (9404)
2015 (12408)
2014 (9796)
2013 (7895)
2012 (8583)
2011 (8979)
2010 (8762)
Location
Africa (191)
Alabama (20)
Alaska (3)
Arizona (76)
Arkansas (1)
Asia (12098)
Australia (1840)
California (3618)
Canada (1155)
China (171)
Colorado (147)
Connecticut (166)
Delaware (70)
Europe (26734)
Florida (547)
Georgia (72)
Idaho (24)
Illinois (182)
India (14)
Indiana (120)
Iowa (9)
Japan (167)
Kansas (36)
Kentucky (17)
Louisiana (8)
Maine (51)
Maryland (356)
Massachusetts (2845)
Michigan (104)
Minnesota (203)
Mississippi (1)
Missouri (32)
Montana (17)
Nebraska (12)
Nevada (46)
New Hampshire (16)
New Jersey (1023)
New Mexico (7)
New York (881)
North Carolina (483)
North Dakota (4)
Northern California (1879)
Ohio (118)
Oklahoma (5)
Oregon (6)
Pennsylvania (624)
Puerto Rico (2)
Rhode Island (21)
South America (292)
South Carolina (17)
Southern California (1355)
Tennessee (63)
Texas (492)
United States (12638)
Utah (112)
Virginia (84)
Washington D.C. (17)
Washington State (300)
West Virginia (2)
Wisconsin (57)
Wyoming (1)
236,707 Results for "cem corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Advanced CEM tracking enables more comprehensive breast cancer detection and care coordination
December 1, 2025
·
2 min read
MedBright AI to Present at CEM Bahamas Small-Cap Conference and Maxim Group’s 2024 Healthcare IT Conference
MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) has announced today that they will be presenting at both the CEM Bahamas Small-Cap Conference, and Maxim Group’s 2024 Healthcare IT Conference in the upcoming week.
January 19, 2024
·
1 min read
Opinion
Regulatory and Economic Turmoil Is More Familiar in Other Countries
Disruptive conditions are typical in non-Western markets. The U.S. industry, thrown into a period of significant change as the Trump administration overhauls HHS and considers implementing tariffs, could learn a thing or two by looking overseas.
April 21, 2025
·
5 min read
·
Cem Zorlular
Press Releases
American Aires to Present at CEM’s In-Person Muskoka Small-Cap Investor Conference on Sept. 28, 2024
September 26, 2024
·
5 min read
Business
CEM Corporation & AmbioPharm Form U.S. Partnership for GMP Peptide Production
CEM Corporation and AmbioPharm, Inc. are excited to announce the formation of a partnership for production of GMP peptides for the global market.
September 14, 2021
·
4 min read
Press Releases
Lyra Therapeutics Provides Corporate Update
January 12, 2026
·
4 min read
Press Releases
Skye Provides 2026 Corporate Outlook
January 12, 2026
·
8 min read
Press Releases
Kiniksa Pharmaceuticals Provides Corporate Update
January 12, 2026
·
11 min read
Press Releases
Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate Outlook
January 13, 2026
·
7 min read
Press Releases
Mereo BioPharma Provides Corporate Update
January 12, 2026
·
9 min read
1 of 23,671
Next
